» Articles » PMID: 23726124

Value of Whole Body MRI and Dynamic Contrast Enhanced MRI in the Diagnosis, Follow-up and Evaluation of Disease Activity and Extent in Multiple Myeloma

Overview
Journal Eur J Radiol
Specialty Radiology
Date 2013 Jun 4
PMID 23726124
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the significance of dynamic contrast enhanced MRI (DCE-MRI) and whole body MRI (WB-MRI) in the diagnosis, prognosis and assessment of therapy for patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM).

Materials And Methods: The retrospective study includes 219 patients providing 463 WB-MRI and DCE-MRI investigations for the subgroups MGUS (n=70), MM active disease (n=126; this includes 70 patients with new diagnosis of MM, according to the International Staging System (ISS): 41.4% ISS stage I, 20.0% ISS stage II, 7.1% ISS stage III, 31.4% insufficient for staging; and 56 patients with '(re-)active disease': 16.07% relapse, 32.14% progressive disease and 51.79% stable disease) and MM remission (n=23; 60.87% complete remission, 17.39% very good partial remission and 21.74% partial remission). Investigations of patients with hereditary multiple exostoses (n=5), neurofibromatosis (n=7) and healthy persons (n=9) were added as control subjects (n=21). WB-MRI evaluation was done by evaluating thirteen skeletal regions, providing a 'skeletal score'. DCE-MRI images of the spine, were analyzed with regions-of-interest and time-intensity-curves (TIC).

Results: All TIC parameters can significantly differentiate between the predefined subgroups (p<0.001). One hundred days after autologous stem cell transplantation a 75% decrease of the slope wash-in value (p<0.001) can be seen. A cubic regression trend between 'skeletal score' and slope wash-in (adj.R(2)=0.412) could demonstrate a significant increase bone marrow perfusion if MM affects more than 10 skeletal regions (p<0.001), associated with a poorer prognosis (p<0.001).

Conclusion: DCE-MRI evaluation of the spine is useful for diagnosis of MM, follow-up after stem cell transplantation and evaluation of disease activity. A combined evaluation with WB-MRI and DCE-MRI provides additional micro-vascular information on the morphologic lesions and could help categorize patients with MM in two different groups to offer useful therapeutic and prognostic advise.

Citing Articles

Recent advances in imaging and artificial intelligence (AI) for quantitative assessment of multiple myeloma.

Liu Y, Huang W, Yang Y, Cai W, Sun Z Am J Nucl Med Mol Imaging. 2024; 14(4):208-229.

PMID: 39309415 PMC: 11411189. DOI: 10.62347/NLLV9295.


Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging.

Den Berghe T, Verberckmoes B, Kint N, Wallaert S, De Vos N, Algoet C Insights Imaging. 2024; 15(1):106.

PMID: 38597979 PMC: 11006637. DOI: 10.1186/s13244-024-01672-1.


Hybrid simultaneous whole-body 2-[F]FDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value results.

Jamet B, Carlier T, Bailly C, Bodet-Milin C, Monnet A, Frampas E Eur Radiol. 2023; 33(9):6438-6447.

PMID: 37022439 DOI: 10.1007/s00330-023-09593-1.


X-ray and MRI Correlation of Bone Tumors Using Histopathology As Gold Standard.

Azad H, Ahmed A, Zafar I, Bhutta M, Rabbani M, Kc H Cureus. 2022; 14(7):e27262.

PMID: 36039258 PMC: 9403219. DOI: 10.7759/cureus.27262.


Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma).

Den Berghe T, Verstraete K, Lecouvet F, Lejoly M, Dutoit J Skeletal Radiol. 2021; 51(1):101-122.

PMID: 34523007 DOI: 10.1007/s00256-021-03903-8.